Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1979 Mar;35(3):443-6.

Inhibition of mitogen-induced human lymphocyte proliferative responses by tetracycline analogues

Inhibition of mitogen-induced human lymphocyte proliferative responses by tetracycline analogues

Y H Thong et al. Clin Exp Immunol. 1979 Mar.

Abstract

The effect of tetracyclines on mitogen-induced proliferative responses of human lymphocytes was examined. The results showed that of the three tetracycline analogues studied, doxycycline possessed the most potent inhibiting effects. This occurred at drug concentrations (1--10 micrograms/ml) easily attainable in serum during conventional dosage schedules. Other investigations have shown that tetracyclines also interfere with neutrophil function. Taken together, these findings may have clinical significance. Recovery from serious infections generally requires some minimal host immune responses, and the immunosuppressive side-effects of tetracyclines may have detrimental effects on patients with debilitating illnesses or impaired immunological defence mechanisms. Furthermore, tetracyclines may share some common properties of conventional immunosuppressive drugs, such as cytotoxicity, teratogenicity and cancerogenicity. The long-term use of tetracyclines for conditions such as chronic bronchitis, bronchiectasis and acne vulgaris needs to be re-examined.

PubMed Disclaimer

References

    1. N Engl J Med. 1963 Nov 7;269:999-1004 - PubMed
    1. Proc Soc Exp Biol Med. 1950 Nov;75(2):367-70 - PubMed
    1. Antimicrob Agents Chemother. 1977 Feb;11(2):318-23 - PubMed
    1. Lancet. 1973 Feb 17;1(7799):382 - PubMed
    1. N Engl J Med. 1973 Sep 20;289(12):604-6 - PubMed

LinkOut - more resources